Managing Prior Authorizations with Artificial Intelligence
AI-driven software can help labs expertly navigate the prior authorization landscape.
Read MorePosted by Steve Halasey | Apr 13, 2020 | Compliance, Computing Systems, Information Technology, Lab Management, Middleware & Software |
AI-driven software can help labs expertly navigate the prior authorization landscape.
Read MorePosted by Steve Halasey | Apr 13, 2020 | Cancer, Molecular Diagnostics, Pancreatic, Specimen Collection & Handling |
Analysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.
Read MorePosted by | Apr 10, 2020 | Cancer, Leukemia, Molecular Diagnostics |
The latest update is beneficial to researchers investigating myeloid disorders, and is now enabled with BCR-ABL fusion gene and KMT2A-PTD detection.
Read MorePosted by | Apr 6, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types |
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read MorePosted by | Mar 31, 2020 | Cancer, Colorectal, Molecular Diagnostics |
The aim of the consortium is to develop a blood test based on transcriptomic and epigenetic biomarkers for early detection and relapse monitoring in CRC patients.
Read More